Top 10 Generic Drug Product Manufacturers (Formulators) in Israel

Robert Gultig

5 January 2026

Top 10 Generic Drug Product Manufacturers (Formulators) in Israel

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Israel has been experiencing steady growth in recent years, with a focus on generic drug products. The country has become a hub for innovative research and development, leading to an increase in the number of generic drug manufacturers. According to recent statistics, the pharmaceutical market in Israel is expected to reach $5.2 billion by 2025, with a compound annual growth rate of 4.2%.

Top 10 Generic Drug Product Manufacturers (Formulators) in Israel:

1. Teva Pharmaceutical Industries: Teva is the largest generic drug manufacturer in Israel, with a market share of over 20%. The company produces a wide range of generic products, including medications for various therapeutic areas.

2. Perrigo Company: Perrigo is a leading manufacturer of over-the-counter and generic prescription pharmaceuticals. The company has a strong presence in the Israeli market, with a focus on high-quality, affordable products.

3. Mylan Laboratories: Mylan is another key player in the Israeli generic drug market, known for its extensive product portfolio and global reach. The company focuses on providing cost-effective alternatives to brand-name medications.

4. Taro Pharmaceuticals: Taro Pharmaceuticals is a subsidiary of Sun Pharmaceutical Industries, one of the largest pharmaceutical companies in India. The company specializes in generic dermatology products and has a significant market share in Israel.

5. Neopharm Group: Neopharm is a leading pharmaceutical company in Israel, with a focus on generic drug formulation and distribution. The company has a strong presence in the Israeli market and exports its products to several countries worldwide.

6. Rafa Laboratories: Rafa Laboratories is a prominent Israeli pharmaceutical company, known for its high-quality generic drug products. The company has a diverse product portfolio and a strong presence in the local market.

7. Dexcel Pharma: Dexcel is a well-established pharmaceutical company in Israel, specializing in the development and manufacturing of generic drugs. The company has a reputation for innovation and quality in the industry.

8. Unipharm: Unipharm is a leading Israeli pharmaceutical company, focused on the production of generic drug formulations. The company has a strong distribution network and a loyal customer base in Israel.

9. Trima Pharmaceuticals: Trima is a reputable generic drug manufacturer in Israel, known for its commitment to quality and affordability. The company offers a wide range of generic products for various therapeutic areas.

10. Biopharm Chemicals: Biopharm is a key player in the Israeli generic drug market, with a focus on research and development. The company is known for its innovative formulations and competitive pricing.

Insights:

The generic drug market in Israel is expected to continue growing in the coming years, driven by factors such as increasing demand for affordable medications and a growing aging population. According to industry forecasts, the Israeli pharmaceutical market is projected to reach $6.8 billion by 2030, with a compound annual growth rate of 5.1%. As competition intensifies, manufacturers will need to focus on innovation and cost-effective production methods to maintain their market share and profitability.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →